Japan extends timeline for approving Fujifilm's Avigan drug for COVID-19
Fujifilm shares slumped last week after it was reported that an interim study showed no clear evidence of efficacy for Avigan in COVID-19 cases.
Fujifilm plans to make flu drug Avigan available for 2 million people by March 2021
Fujifilm Holdings Corp. said Friday it is on course to supply the flu drug Avigan for 2 million COVID-19 patients by next March, meeting a target set by the government to ramp up production of the potential but yet unapproved coronavirus treatment. "We plan to ...
No pause in coronavirus trial for Avigan, Japan's lead researcher says
The lead researcher in the coronavirus trial for flu drug Avigan says it’s too early to make a call on whether it works and shrugged off negative reports about the interim results, saying patients are still being enrolled. The final results of the trial for ...
Drug Avigan that was pushed by Abe falls short in COVID-19 trials
The lack of results have raised doubts about its approval by the end of this month, as sought by the government.
A tale of two Japanese drugs in tests to fight COVID-19
Avigan and camostat are undergoing trials as they may be effective in treating illnesses brought on by coronavirus.
Japan to offer anti-flu drug Avigan to 38 countries as early as this week
In a related move, the health ministry is expected to soon give approval to an antigen test that can quickly detect coronavirus infections.
Abe touts Avigan as COVID-19 treatment despite experts urging caution
Medical experts warn the drug, also known as favipiravir, may cause birth defects and it cannot be administered to expecting mothers or those who may become pregnant.
Kaneka to supply ingredients for Fujifilm's Avigan drug for COVID-19 treatment
Kaneka Corp. has said it will supply ingredients for Fujifilm Corp.'s anti-influenza drug Avigan, which is expected to work against COVID-19. Kaneka and Fujifilm have reached an agreement on the supply of ingredients, as Fujifilm aims to boost its monthly output capacity for the drug ...
Fujifilm to boost capacity to make COVID-19 treatment Avigan
Fujifilm Holdings Corp. said Wednesday it has expanded manufacturing capacity to "significantly increase" production of its anti-flu drug Avigan that is being tested as a treatment for COVID-19. Fujifilm expects to increase the production of Avigan up to 100,000 treatment courses by July 2020, about ...
Coronavirus drug hopefuls are cheap to make but may quickly be in short supply
Drugs being repurposed in hopes they will help against COVID-19 cost relatively little to make but may prove challenging to produce in quantities needed for a pandemic, a drug pricing expert has said. "Any pharmaceutical company manufacturing any treatment currently in clinical trials against coronavirus ...
Japan to offer anti-flu Avigan drug to 20 virus-hit nations for free
Japan plans to provide the anti-flu drug Avigan for free to 20 countries hoping to use it to treat coronavirus patients, Foreign Minister Toshimitsu Motegi said Tuesday. The 20 countries receiving the drug, which is currently undergoing clinical tests, include Bulgaria, the Czech Republic, Indonesia, ...
Japan to boost Avigan drug stockpile as part of coronavirus stimulus
Japan is considering increasing the stockpile of Fujifilm Holding Corp.'s Avigan anti-flu drug during this fiscal year so it can be used to treat 2 million people.
